Skip to main content
Top
Published in: BMC Cancer 1/2010

Open Access 01-12-2010 | Research article

Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells

Authors: Hari Raghu, Prasanna Kumar Sodadasu, Rama Rao Malla, Christopher S Gondi, Norman Estes, Jasti S Rao

Published in: BMC Cancer | Issue 1/2010

Login to get access

Abstract

Background

uPAR and MMP-9, which play critical roles in tumor cell invasion, migration and angiogenesis, have been shown to be associated with lipid rafts.

Methods

To investigate whether cholesterol could regulate uPAR and MMP-9 in breast carcinoma, we used MβCD (methyl beta cyclodextrin, which extracts cholesterol from lipid rafts) to disrupt lipid rafts and studied its effect on breast cancer cell migration, invasion, angiogenesis and signaling.

Results

Morphological evidence showed the association of uPAR with lipid rafts in breast carcinoma cells. MβCD treatment significantly reduced the colocalization of uPAR and MMP-9 with lipid raft markers and also significantly reduced uPAR and MMP-9 at both the protein and mRNA levels. Spheroid migration and invasion assays showed inhibition of breast carcinoma cell migration and invasion after MβCD treatment. In vitro angiogenesis studies showed a significant decrease in the angiogenic potential of cells pretreated with MβCD. MβCD treatment significantly reduced the levels of MMP-9 and uPAR in raft fractions of MDA-MB-231 and ZR 751 cells. Phosphorylated forms of Src, FAK, Cav, Akt and ERK were significantly inhibited upon MβCD treatment. Increased levels of soluble uPAR were observed upon MβCD treatment. Cholesterol supplementation restored uPAR expression to basal levels in breast carcinoma cell lines. Increased colocalization of uPAR with the lysosomal marker LAMP1 was observed in MβCD-treated cells when compared with untreated cells.

Conclusion

Taken together, our results suggest that cholesterol levels in lipid rafts are critical for the migration, invasion, and angiogenesis of breast carcinoma cells and could be a critical regulatory factor in these cancer cell processes mediated by uPAR and MMP-9.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brown DA, London E: Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol. 1998, 14: 111-136. 10.1146/annurev.cellbio.14.1.111.CrossRefPubMed Brown DA, London E: Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol. 1998, 14: 111-136. 10.1146/annurev.cellbio.14.1.111.CrossRefPubMed
2.
go back to reference Langlet C, Bernard AM, Drevot P, He HT: Membrane rafts and signaling by the multichain immune recognition receptors. Curr Opin Immunol. 2000, 12: 250-255. 10.1016/S0952-7915(00)00084-4.CrossRefPubMed Langlet C, Bernard AM, Drevot P, He HT: Membrane rafts and signaling by the multichain immune recognition receptors. Curr Opin Immunol. 2000, 12: 250-255. 10.1016/S0952-7915(00)00084-4.CrossRefPubMed
3.
go back to reference Raghu H, Sharma-Walia N, Veettil MV, Sadagopan S, Caballero A, Sivakumar R, Varga L, Bottero V, Chandran B: Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dispensable for binding and entry. J Virol. 2007, 81: 7941-7959. 10.1128/JVI.02848-06.CrossRefPubMedPubMedCentral Raghu H, Sharma-Walia N, Veettil MV, Sadagopan S, Caballero A, Sivakumar R, Varga L, Bottero V, Chandran B: Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dispensable for binding and entry. J Virol. 2007, 81: 7941-7959. 10.1128/JVI.02848-06.CrossRefPubMedPubMedCentral
4.
go back to reference Edidin M: Membrane cholesterol, protein phosphorylation, and lipid rafts. Sci STKE. 2001, 67: E1- Edidin M: Membrane cholesterol, protein phosphorylation, and lipid rafts. Sci STKE. 2001, 67: E1-
5.
go back to reference Zajchowski LD, Robbins SM: Lipid rafts and little caves. Compartmentalized signalling in membrane microdomains. Eur J Biochem. 2002, 269: 737-752. 10.1046/j.0014-2956.2001.02715.x.CrossRefPubMed Zajchowski LD, Robbins SM: Lipid rafts and little caves. Compartmentalized signalling in membrane microdomains. Eur J Biochem. 2002, 269: 737-752. 10.1046/j.0014-2956.2001.02715.x.CrossRefPubMed
6.
go back to reference Sahores M, Prinetti A, Chiabrando G, Blasi F, Sonnino S: uPA binding increases UPAR localization to lipid rafts and modifies the receptor microdomain composition. Biochim Biophys Acta. 2008, 1778: 250-259. 10.1016/j.bbamem.2007.09.030.CrossRefPubMed Sahores M, Prinetti A, Chiabrando G, Blasi F, Sonnino S: uPA binding increases UPAR localization to lipid rafts and modifies the receptor microdomain composition. Biochim Biophys Acta. 2008, 1778: 250-259. 10.1016/j.bbamem.2007.09.030.CrossRefPubMed
7.
go back to reference Cunningham O, Andolfo A, Santovito ML, Iuzzolino L, Blasi F, Sidenius N: Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J. 2003, 22: 5994-6003. 10.1093/emboj/cdg588.CrossRefPubMedPubMedCentral Cunningham O, Andolfo A, Santovito ML, Iuzzolino L, Blasi F, Sidenius N: Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J. 2003, 22: 5994-6003. 10.1093/emboj/cdg588.CrossRefPubMedPubMedCentral
8.
go back to reference Sitrin RG, Johnson DR, Pan PM, Harsh DM, Huang J, Petty HR, Blackwood RA: Lipid raft compartmentalization of urokinase receptor signaling in human neutrophils. Am J Respir Cell Mol Biol. 2004, 30: 233-241. 10.1165/rcmb.2003-0079OC.CrossRefPubMed Sitrin RG, Johnson DR, Pan PM, Harsh DM, Huang J, Petty HR, Blackwood RA: Lipid raft compartmentalization of urokinase receptor signaling in human neutrophils. Am J Respir Cell Mol Biol. 2004, 30: 233-241. 10.1165/rcmb.2003-0079OC.CrossRefPubMed
9.
go back to reference Nagase H, Woessner JF: Matrix metalloproteinases. J Biol Chem. 1999, 274: 21491-21494. 10.1074/jbc.274.31.21491.CrossRefPubMed Nagase H, Woessner JF: Matrix metalloproteinases. J Biol Chem. 1999, 274: 21491-21494. 10.1074/jbc.274.31.21491.CrossRefPubMed
10.
go back to reference Coussens LM, Tinkle CL, Hanahan D, Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 2000, 103: 481-490. 10.1016/S0092-8674(00)00139-2.CrossRefPubMedPubMedCentral Coussens LM, Tinkle CL, Hanahan D, Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 2000, 103: 481-490. 10.1016/S0092-8674(00)00139-2.CrossRefPubMedPubMedCentral
11.
go back to reference Kahari VM, Saarialho-Kere U: Matrix metalloproteinases in skin. Exp Dermatol. 1997, 6: 199-213. 10.1111/j.1600-0625.1997.tb00164.x.CrossRefPubMed Kahari VM, Saarialho-Kere U: Matrix metalloproteinases in skin. Exp Dermatol. 1997, 6: 199-213. 10.1111/j.1600-0625.1997.tb00164.x.CrossRefPubMed
12.
go back to reference Mathews-Roth MM, Michel JL, Wise RJ: Amelioration of the metabolic defect in erythropoietic protoporphyria by expression of human ferrochelatase in cultured cells. J Invest Dermatol. 1995, 104: 497-499. 10.1111/1523-1747.ep12605930.CrossRefPubMed Mathews-Roth MM, Michel JL, Wise RJ: Amelioration of the metabolic defect in erythropoietic protoporphyria by expression of human ferrochelatase in cultured cells. J Invest Dermatol. 1995, 104: 497-499. 10.1111/1523-1747.ep12605930.CrossRefPubMed
13.
go back to reference Ravanti L, Kahari VM: Matrix metalloproteinases in wound repair. Int J Mol Med. 2000, 6: 391-407.PubMed Ravanti L, Kahari VM: Matrix metalloproteinases in wound repair. Int J Mol Med. 2000, 6: 391-407.PubMed
14.
go back to reference Zhang Q, Furukawa K, Chen HH, Sakakibara T, Urano T, Furukawa K: Metastatic potential of mouse Lewis lung cancer cells is regulated via ganglioside GM1 by modulating the matrix metalloprotease-9 localization in lipid rafts. J Biol Chem. 2006, 281: 18145-18155. 10.1074/jbc.M512566200.CrossRefPubMed Zhang Q, Furukawa K, Chen HH, Sakakibara T, Urano T, Furukawa K: Metastatic potential of mouse Lewis lung cancer cells is regulated via ganglioside GM1 by modulating the matrix metalloprotease-9 localization in lipid rafts. J Biol Chem. 2006, 281: 18145-18155. 10.1074/jbc.M512566200.CrossRefPubMed
15.
go back to reference Maxfield F, Tabas I: Role of cholesterol and lipid organization in disease. Nature. 2005, 438: 612-621. 10.1038/nature04399.CrossRefPubMed Maxfield F, Tabas I: Role of cholesterol and lipid organization in disease. Nature. 2005, 438: 612-621. 10.1038/nature04399.CrossRefPubMed
16.
go back to reference Opitz JM, de la Cruz F: Cholesterol metabolism in the RSH/Smith-Lemli-Opitz syndrome: summary of an NICHD conference. Am J Med Genet. 1994, 50: 326-338. 10.1002/ajmg.1320500406.CrossRefPubMed Opitz JM, de la Cruz F: Cholesterol metabolism in the RSH/Smith-Lemli-Opitz syndrome: summary of an NICHD conference. Am J Med Genet. 1994, 50: 326-338. 10.1002/ajmg.1320500406.CrossRefPubMed
17.
go back to reference Silvius JR: Role of cholesterol in lipid raft formation: lessons from lipid model systems. Biochim Biophys Acta. 2003, 1610: 174-183. 10.1016/S0005-2736(03)00016-6.CrossRefPubMed Silvius JR: Role of cholesterol in lipid raft formation: lessons from lipid model systems. Biochim Biophys Acta. 2003, 1610: 174-183. 10.1016/S0005-2736(03)00016-6.CrossRefPubMed
18.
go back to reference Barman S, Nayak DP: Lipid raft disruption by cholesterol depletion enhances influenza A virus budding from MDCK cells. J Virol. 2007, 81: 12169-12178. 10.1128/JVI.00835-07.CrossRefPubMedPubMedCentral Barman S, Nayak DP: Lipid raft disruption by cholesterol depletion enhances influenza A virus budding from MDCK cells. J Virol. 2007, 81: 12169-12178. 10.1128/JVI.00835-07.CrossRefPubMedPubMedCentral
19.
go back to reference Freeman MR, Solomon KR: Cholesterol and prostate cancer. J Cell Biochem. 2004, 91: 54-69. 10.1002/jcb.10724.CrossRefPubMed Freeman MR, Solomon KR: Cholesterol and prostate cancer. J Cell Biochem. 2004, 91: 54-69. 10.1002/jcb.10724.CrossRefPubMed
20.
go back to reference Kolanjiappan K, Ramachandran CR, Manoharan S: Biochemical changes in tumor tissues of oral cancer patients. Clin Biochem. 2003, 36: 61-65. 10.1016/S0009-9120(02)00421-6.CrossRefPubMed Kolanjiappan K, Ramachandran CR, Manoharan S: Biochemical changes in tumor tissues of oral cancer patients. Clin Biochem. 2003, 36: 61-65. 10.1016/S0009-9120(02)00421-6.CrossRefPubMed
21.
go back to reference Bennis F, Favre G, Le GF, Soula G: Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549. Int J Cancer. 1993, 55: 640-645. 10.1002/ijc.2910550421.CrossRefPubMed Bennis F, Favre G, Le GF, Soula G: Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549. Int J Cancer. 1993, 55: 640-645. 10.1002/ijc.2910550421.CrossRefPubMed
22.
go back to reference El-Sohemy A, Archer MC: Inhibition of N-methyl-N-nitrosourea-and 7,12-dimethylbenz[a] anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-Ras mutations. Carcinogenesis. 2000, 21: 827-831. 10.1093/carcin/21.4.827.CrossRefPubMed El-Sohemy A, Archer MC: Inhibition of N-methyl-N-nitrosourea-and 7,12-dimethylbenz[a] anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-Ras mutations. Carcinogenesis. 2000, 21: 827-831. 10.1093/carcin/21.4.827.CrossRefPubMed
23.
go back to reference Gondi CS, Kandhukuri N, Kondraganti S, Gujrati M, Olivero WC, Dinh DH, Rao JS: RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells. Mol Cancer Ther. 2006, 5: 3197-3208. 10.1158/1535-7163.MCT-05-0531.CrossRefPubMedPubMedCentral Gondi CS, Kandhukuri N, Kondraganti S, Gujrati M, Olivero WC, Dinh DH, Rao JS: RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells. Mol Cancer Ther. 2006, 5: 3197-3208. 10.1158/1535-7163.MCT-05-0531.CrossRefPubMedPubMedCentral
24.
go back to reference Kunigal S, Lakka SS, Gondi CS, Estes N, Rao JS: RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int J Cancer. 2007, 121: 2307-2316. 10.1002/ijc.22962.CrossRefPubMedPubMedCentral Kunigal S, Lakka SS, Gondi CS, Estes N, Rao JS: RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int J Cancer. 2007, 121: 2307-2316. 10.1002/ijc.22962.CrossRefPubMedPubMedCentral
25.
go back to reference Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP: Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem. 1996, 271: 9690-9697. 10.1074/jbc.271.16.9690.CrossRefPubMed Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP: Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem. 1996, 271: 9690-9697. 10.1074/jbc.271.16.9690.CrossRefPubMed
26.
go back to reference Labrecque L, Royal I, Surprenant DS, Patterson C, Gingras D, Beliveau R: Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol Biol Cell. 2003, 14: 334-347. 10.1091/mbc.E02-07-0379.CrossRefPubMedPubMedCentral Labrecque L, Royal I, Surprenant DS, Patterson C, Gingras D, Beliveau R: Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol Biol Cell. 2003, 14: 334-347. 10.1091/mbc.E02-07-0379.CrossRefPubMedPubMedCentral
27.
go back to reference Cortese K, Sahores M, Madsen CD, Tacchetti C, Blasi F: Clathrin and LRP-1-independent constitutive endocytosis and recycling of uPAR. PLoS One. 2008, 3: e3730-10.1371/journal.pone.0003730.CrossRefPubMedPubMedCentral Cortese K, Sahores M, Madsen CD, Tacchetti C, Blasi F: Clathrin and LRP-1-independent constitutive endocytosis and recycling of uPAR. PLoS One. 2008, 3: e3730-10.1371/journal.pone.0003730.CrossRefPubMedPubMedCentral
28.
go back to reference Li YC, Park MJ, Ye SK, Kim CW, Kim YN: Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am J Pathol. 2006, 168: 1107-1118. 10.2353/ajpath.2006.050959.CrossRefPubMedPubMedCentral Li YC, Park MJ, Ye SK, Kim CW, Kim YN: Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am J Pathol. 2006, 168: 1107-1118. 10.2353/ajpath.2006.050959.CrossRefPubMedPubMedCentral
29.
go back to reference Storch CH, Ehehalt R, Haefeli WE, Weiss J: Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro. J Pharmacol Exp Ther. 2007, 323: 257-264. 10.1124/jpet.107.122994.CrossRefPubMed Storch CH, Ehehalt R, Haefeli WE, Weiss J: Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro. J Pharmacol Exp Ther. 2007, 323: 257-264. 10.1124/jpet.107.122994.CrossRefPubMed
30.
go back to reference Yokota T, Matsuzaki Y, Koyama M, Hitomi T, Kawanaka M, Enoki-Konishi M, Okuyama Y, Takayasu J, Nishino H, Nishikawa A, Osawa T, Sakai T: Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells. Cancer Sci. 2007, 98: 1447-1453. 10.1111/j.1349-7006.2007.00560.x.CrossRefPubMed Yokota T, Matsuzaki Y, Koyama M, Hitomi T, Kawanaka M, Enoki-Konishi M, Okuyama Y, Takayasu J, Nishino H, Nishikawa A, Osawa T, Sakai T: Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells. Cancer Sci. 2007, 98: 1447-1453. 10.1111/j.1349-7006.2007.00560.x.CrossRefPubMed
31.
go back to reference Kunigal S, Gondi CS, Gujrati M, Lakka SS, Dinh DH, Olivero WC, Rao JS: SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA. Int J Oncol. 2006, 29: 1349-1357.PubMedPubMedCentral Kunigal S, Gondi CS, Gujrati M, Lakka SS, Dinh DH, Olivero WC, Rao JS: SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA. Int J Oncol. 2006, 29: 1349-1357.PubMedPubMedCentral
32.
go back to reference DiVizio D, Solomon KR, Freeman MR: Cholesterol and cholesterol-rich membranes in prostate cancer: an update. Tumori. 2008, 94: 633-639. DiVizio D, Solomon KR, Freeman MR: Cholesterol and cholesterol-rich membranes in prostate cancer: an update. Tumori. 2008, 94: 633-639.
33.
go back to reference Hager MH, Solomon KR, Freeman MR: The role of cholesterol in prostate cancer. Curr Opin Clin Nutr Metab Care. 2006, 9: 379-385. 10.1097/01.mco.0000232896.66791.62.CrossRefPubMed Hager MH, Solomon KR, Freeman MR: The role of cholesterol in prostate cancer. Curr Opin Clin Nutr Metab Care. 2006, 9: 379-385. 10.1097/01.mco.0000232896.66791.62.CrossRefPubMed
34.
go back to reference Foster LJ, De Hoog CL, Mann M: Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci USA. 2003, 100: 5813-5818. 10.1073/pnas.0631608100.CrossRefPubMedPubMedCentral Foster LJ, De Hoog CL, Mann M: Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci USA. 2003, 100: 5813-5818. 10.1073/pnas.0631608100.CrossRefPubMedPubMedCentral
35.
go back to reference Hitosugi T, Sato M, Sasaki K, Umezawa Y: Lipid raft specific knockdown of SRC family kinase activity inhibits cell adhesion and cell cycle progression of breast cancer cells. Cancer Res. 2007, 67: 8139-8148. 10.1158/0008-5472.CAN-06-4539.CrossRefPubMed Hitosugi T, Sato M, Sasaki K, Umezawa Y: Lipid raft specific knockdown of SRC family kinase activity inhibits cell adhesion and cell cycle progression of breast cancer cells. Cancer Res. 2007, 67: 8139-8148. 10.1158/0008-5472.CAN-06-4539.CrossRefPubMed
36.
go back to reference Piazza TM, Lu JC, Carver KC, Schuler LA: SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells. Mol Endocrinol. 2009, 23: 202-212. 10.1210/me.2008-0341.CrossRefPubMed Piazza TM, Lu JC, Carver KC, Schuler LA: SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells. Mol Endocrinol. 2009, 23: 202-212. 10.1210/me.2008-0341.CrossRefPubMed
37.
go back to reference Adachi Y, Lakka SS, Chandrasekar N, Yanamandra N, Gondi CS, Mohanam S, Dinh DH, Olivero WC, Gujrati M, Tamiya T, Ohmoto T, Kouraklis G, Aggarwal B, Rao JS: Down-regulation of integrin alpha (v) beta (3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes. J Biol Chem. 2001, 276: 47171-47177. 10.1074/jbc.M104334200.CrossRefPubMed Adachi Y, Lakka SS, Chandrasekar N, Yanamandra N, Gondi CS, Mohanam S, Dinh DH, Olivero WC, Gujrati M, Tamiya T, Ohmoto T, Kouraklis G, Aggarwal B, Rao JS: Down-regulation of integrin alpha (v) beta (3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes. J Biol Chem. 2001, 276: 47171-47177. 10.1074/jbc.M104334200.CrossRefPubMed
38.
go back to reference Gopalakrishna P, Chaubey SK, Manogaran PS, Pande G: Modulation of alpha5beta1 integrin functions by the phospholipid and cholesterol contents of cell membranes. J Cell Biochem. 2000, 77: 517-528. 10.1002/(SICI)1097-4644(20000615)77:4<517::AID-JCB1>3.0.CO;2-6.CrossRefPubMed Gopalakrishna P, Chaubey SK, Manogaran PS, Pande G: Modulation of alpha5beta1 integrin functions by the phospholipid and cholesterol contents of cell membranes. J Cell Biochem. 2000, 77: 517-528. 10.1002/(SICI)1097-4644(20000615)77:4<517::AID-JCB1>3.0.CO;2-6.CrossRefPubMed
39.
go back to reference Park EK, Park MJ, Lee SH, Li YC, Kim J, Lee JS, Lee JW, Ye SK, Park JW, Kim CW, Park BK, Kim YN: Cholesterol depletion induces anoikis-like apoptosis via FAK down-regulation and caveolae internalization. J Pathol. 2009, 218: 337-349. 10.1002/path.2531.CrossRefPubMed Park EK, Park MJ, Lee SH, Li YC, Kim J, Lee JS, Lee JW, Ye SK, Park JW, Kim CW, Park BK, Kim YN: Cholesterol depletion induces anoikis-like apoptosis via FAK down-regulation and caveolae internalization. J Pathol. 2009, 218: 337-349. 10.1002/path.2531.CrossRefPubMed
40.
go back to reference Carver LA, Schnitzer JE, Anderson RG, Mohla S: Role of caveolae and lipid rafts in cancer: workshop summary and future needs. Cancer Res. 2003, 63: 6571-6574.PubMed Carver LA, Schnitzer JE, Anderson RG, Mohla S: Role of caveolae and lipid rafts in cancer: workshop summary and future needs. Cancer Res. 2003, 63: 6571-6574.PubMed
41.
go back to reference Fedida-Metula S, Elhyany S, Tsory S, Segal S, Hershfinkel M, Sekler I, Fishman D: Targeting lipid rafts inhibits protein kinase B by disrupting calcium homeostasis and attenuates malignant properties of melanoma cells. Carcinogenesis. 2008, 29: 1546-1554. 10.1093/carcin/bgn146.CrossRefPubMed Fedida-Metula S, Elhyany S, Tsory S, Segal S, Hershfinkel M, Sekler I, Fishman D: Targeting lipid rafts inhibits protein kinase B by disrupting calcium homeostasis and attenuates malignant properties of melanoma cells. Carcinogenesis. 2008, 29: 1546-1554. 10.1093/carcin/bgn146.CrossRefPubMed
42.
go back to reference Zhuang L, Kim J, Adam R, Solomon K, Freeman MR: Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest. 2005, 115: 959-968.CrossRefPubMedPubMedCentral Zhuang L, Kim J, Adam R, Solomon K, Freeman MR: Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest. 2005, 115: 959-968.CrossRefPubMedPubMedCentral
43.
go back to reference Cremesti AE, Goni FM, Kolesnick R: Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome?. FEBS Lett. 2002, 531: 47-53. 10.1016/S0014-5793(02)03489-0.CrossRefPubMed Cremesti AE, Goni FM, Kolesnick R: Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome?. FEBS Lett. 2002, 531: 47-53. 10.1016/S0014-5793(02)03489-0.CrossRefPubMed
44.
go back to reference Dolo V, D'Ascenzo S, Violini S, Pompucci L, Festuccia C, Ginestra A, Vittorelli ML, Canevari S, Pavan A: Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin Exp Metastasis. 1999, 17: 131-140. 10.1023/A:1006500406240.CrossRefPubMed Dolo V, D'Ascenzo S, Violini S, Pompucci L, Festuccia C, Ginestra A, Vittorelli ML, Canevari S, Pavan A: Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin Exp Metastasis. 1999, 17: 131-140. 10.1023/A:1006500406240.CrossRefPubMed
45.
go back to reference Dolo V, Ginestra A, Cassara D, Violini S, Lucania G, Torrisi MR, Nagase H, Canevari S, Pavan A, Vittorelli ML: Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res. 1998, 58: 4468-4474.PubMed Dolo V, Ginestra A, Cassara D, Violini S, Lucania G, Torrisi MR, Nagase H, Canevari S, Pavan A, Vittorelli ML: Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res. 1998, 58: 4468-4474.PubMed
46.
go back to reference Folkman J, Shing Y: Angiogenesis. J Biol Chem. 1992, 267: 10931-10934.PubMed Folkman J, Shing Y: Angiogenesis. J Biol Chem. 1992, 267: 10931-10934.PubMed
47.
go back to reference Ginestra A, Monea S, Seghezzi G, Dolo V, Nagase H, Mignatti P, Vittorelli ML: Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J Biol Chem. 1997, 272: 17216-17222. 10.1074/jbc.272.27.17216.CrossRefPubMed Ginestra A, Monea S, Seghezzi G, Dolo V, Nagase H, Mignatti P, Vittorelli ML: Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J Biol Chem. 1997, 272: 17216-17222. 10.1074/jbc.272.27.17216.CrossRefPubMed
48.
go back to reference Kim CW, Lee HM, Lee TH, Kang C, Kleinman HK, Gho YS: Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res. 2002, 62: 6312-6317.PubMed Kim CW, Lee HM, Lee TH, Kang C, Kleinman HK, Gho YS: Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res. 2002, 62: 6312-6317.PubMed
49.
go back to reference Himelstein BP, Lee EJ, Sato H, Seiki M, Muschel RJ: Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat. Clin Exp Metastasis. 1998, 16: 169-177. 10.1023/A:1006576305405.CrossRefPubMed Himelstein BP, Lee EJ, Sato H, Seiki M, Muschel RJ: Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat. Clin Exp Metastasis. 1998, 16: 169-177. 10.1023/A:1006576305405.CrossRefPubMed
50.
go back to reference Kim S, Kim Y, Lee Y, Cho KH, Kim KH, Chung JH: Cholesterol inhibits MMP-9 expression in human epidermal keratinocytes and HaCaT cells. FEBS Lett. 2007, 581: 3869-3874. 10.1016/j.febslet.2007.06.074.CrossRefPubMed Kim S, Kim Y, Lee Y, Cho KH, Kim KH, Chung JH: Cholesterol inhibits MMP-9 expression in human epidermal keratinocytes and HaCaT cells. FEBS Lett. 2007, 581: 3869-3874. 10.1016/j.febslet.2007.06.074.CrossRefPubMed
Metadata
Title
Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells
Authors
Hari Raghu
Prasanna Kumar Sodadasu
Rama Rao Malla
Christopher S Gondi
Norman Estes
Jasti S Rao
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2010
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-10-647

Other articles of this Issue 1/2010

BMC Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine